David L. DeMets

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi et al. · New England Journal of Medicine · 2019 · 6.9K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Brian Claggett et al. · New England Journal of Medicine · 2022 · 2.7K citations · Full text

Medicine, Cardiology, Pharmacology +17

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Andrew E. Epstein, John Dimarco, Kenneth A. Ellenbogen et al. · Circulation · 2012 · 1.5K citations · Full text

Medicine, Cardiology, Internal Medicine +17

Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure

Milton Packer, Michael B. Fowler, Ellen B. Roecker et al. · Circulation · 2002 · 1.3K citations

Medicine, Cardiology, Pharmacology +16